Proliferative Vitreoretinopathy (PVR) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Apr 2022	37	Global Markets Direct	ASDR-600472

Published: Apr 2022 - Pages : 37 - Publisher : Global Markets Direct - Report code : ASDR-600472

Aldeyra Therapeutics Inc
Aptitude Medical Systems Inc
Focal Point Pharmaceuticals Inc
Novartis AG
Panag Pharma Inc
Ractigen Therapeutics Inc